A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome

NCT02611609 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL: MultiStem
BIOLOGICAL: MultiStem
BIOLOGICAL: Placebo

Sponsor

Healios K.K.

Collaborators

[object Object]
[object Object]